These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27286797)

  • 1. Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.
    Mangani D; Weller M; Seyed Sadr E; Willscher E; Seystahl K; Reifenberger G; Tabatabai G; Binder H; Schneider H
    Neuro Oncol; 2016 Dec; 18(12):1610-1621. PubMed ID: 27286797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
    Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
    Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer.
    Zhang J; Deng YT; Liu J; Gan L; Jiang Y
    Cancer Biol Ther; 2024 Dec; 25(1):2366451. PubMed ID: 38857055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
    Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
    Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.
    Osterberg N; Ferrara N; Vacher J; Gaedicke S; Niedermann G; Weyerbrock A; Doostkam S; Schaefer HE; Plate KH; Machein MR
    Neuro Oncol; 2016 Jul; 18(7):939-49. PubMed ID: 26951383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.
    Dituri F; Mazzocca A; Fernando J; Peidrò FJ; Papappicco P; Fabregat I; De Santis F; Paradiso A; Sabbà C; Giannelli G
    PLoS One; 2013; 8(6):e67109. PubMed ID: 23826206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.
    Herbertz S; Sawyer JS; Stauber AJ; Gueorguieva I; Driscoll KE; Estrem ST; Cleverly AL; Desaiah D; Guba SC; Benhadji KA; Slapak CA; Lahn MM
    Drug Des Devel Ther; 2015; 9():4479-99. PubMed ID: 26309397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
    Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
    Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tumor-promoting role for soluble TβRIII in glioblastoma.
    Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
    Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration.
    Wang X; Ma W; Han S; Meng Z; Zhao L; Yin Y; Wang Y; Li J
    Sci Rep; 2017 Aug; 7(1):9672. PubMed ID: 28852052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
    Mirzoeva S; Franzen CA; Pelling JC
    Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition.
    Silginer M; Papa E; Szabó E; Vasella F; Pruschy M; Stroh C; Roth P; Weiss T; Weller M
    Acta Neuropathol Commun; 2023 Mar; 11(1):41. PubMed ID: 36915128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin control of the transforming growth factor-β pathway in glioblastoma.
    Roth P; Silginer M; Goodman SL; Hasenbach K; Thies S; Maurer G; Schraml P; Tabatabai G; Moch H; Tritschler I; Weller M
    Brain; 2013 Feb; 136(Pt 2):564-76. PubMed ID: 23378223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.
    Gagner JP; Sarfraz Y; Ortenzi V; Alotaibi FM; Chiriboga LA; Tayyib AT; Douglas GJ; Chevalier E; Romagnoli B; Tuffin G; Schmitt M; Lemercier G; Dembowsky K; Zagzag D
    Am J Pathol; 2017 Sep; 187(9):2080-2094. PubMed ID: 28734730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway.
    Wang S; Yin J; Ge M; Dai Z; Li Y; Si J; Ma K; Li L; Yao S
    Biomed Pharmacother; 2016 Mar; 78():280-290. PubMed ID: 26898453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
    Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S
    Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.